发明名称 |
CYTOTOXICITY-INDUCING THERAPEUTIC AGENT |
摘要 |
PROBLEM TO BE SOLVED: To provide multispecific antigen-binding molecules that can treat cancer through cytotoxic activity of T cells to target cancer tissue containing a glypican 3 expression cell by allowing T cells to approach target cancer tissue, the molecules being a molecular type with high production efficiency; to provide production methods of the antigen-binding molecules; and to provide pharmaceutical compositions containing the antigen-binding molecules as an active ingredient.SOLUTION: The invention relates to a bispecific antibody in which an antibody variable region having glypican 3 avidity, an antibody variable region having T cell receptor complex avidity, and a common L chain variable region are antibody variable regions having a specific amino acid sequence.SELECTED DRAWING: None |
申请公布号 |
JP2016166174(A) |
申请公布日期 |
2016.09.15 |
申请号 |
JP20160023218 |
申请日期 |
2016.02.10 |
申请人 |
CHUGAI PHARMACEUT CO LTD |
发明人 |
NEZU JUNICHI;NARITA ATSUSHI;ISHIGURO TAKAHIRO;SAKURAI MIKA;SHIRAIWA HIROTAKE;HIRONIWA NAOKA;IGAWA TOMOYUKI;KAWAI YUMIKO |
分类号 |
C07K16/46;A61K39/395;A61P35/00;A61P37/04;A61P43/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12P21/08 |
主分类号 |
C07K16/46 |
代理机构 |
|
代理人 |
|
主权项 |
|
地址 |
|